المنشورات طباعة DuBrock HM, Wagner TE, Carlson K, Carpenter CL, Awasthi S, Attia ZI, Frantz RP, Friedman PA, Kapa S, Annis J, Brittain EL, Hemnes AR, Asirvatham SJ, Babu M, Prasad A, Yoo U, Barve R, Selej M, Agron P, Kogan E, Quinn D, Dunnmon P, Khan N, Soundararajan V. An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension. Eur Respir J. 2024 Jun 27 Epub 2024 June 27 View PubMed Balasubramanian A, Larive AB, Horn EM, DuBrock HM, Mehra R, Jacob MS, Hemnes AR, Leopold JA, Radeva MK, Hill NS, Erzurum SC, Rosenzweig EB, Frantz RP, Rischard FP, Beck GJ, Hassoun PM, Mathai SC, PVDOMICS Study Group. Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension. Chest. 2024 Jun; 165 (6):1493-1504 Epub 2024 Feb 12 View PubMed Busebee B, Watt KD, Dupuy-McCauley K, DuBrock H. Sleep disturbances in chronic liver disease. Liver Transpl. 2024 Mar 27 [Epub ahead of print] View PubMed Weatherald J, Nathan SD, El-Kersh K, Argula RG, DuBrock HM, Rischard FP, Cassady SJ, Tarver J, Levine DJ, Tapson VF, Deng C, Shen E, Das M, Waxman AB. Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study. BMJ Open Respir Res. 2024 Mar 22; 11 (1) View PubMed Kim NH, Chin KM, McLaughlin VV, DuBrock H, Restrepo-Jaramillo R, Safdar Z, MacDonald G, Martin N, Rosenberg D, Solonets M, Channick R. Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies. Pulm Ther. 2024 Mar; 10 (1):85-107 Epub 2024 Jan 07 View PubMed Bailey ME, Durst L, Cajigas HR, Kane GC, Krowka MJ, Kushwaha SS, McCully RB, Murphy JG, Reddy YN, Frantz RP, DuBrock HM. Using PAH-SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease. Pulm Circ. 2024 Jan; 14 (1):e12343 Epub 2024 Feb 10 View PubMed Del Valle KT, Krowka MJ, Schinstock CA, Nath KA, Burger CD, Reddy YN, Frantz RP, Prakash YS, DuBrock HM. Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study. Pulm Circ. 2024 Jan; 14 (1):e12341 Epub 2024 Feb 10 View PubMed Bailey M, DuBrock HM. Pulmonary hypertension patient perspectives toward pulmonary rehabilitation. Pulm Circ. 2024 Jan; 14 (1):e12338 Epub 2024 Jan 24 View PubMed DuBrock HM, Germack HD, Gauthier-Loiselle M, Linder J, Satija A, Manceur AM, Cloutier M, Lefebvre P, Panjabi S, Frantz RP. Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH). Pharmacoecon Open. 2024 Jan; 8 (1):133-146 Epub 2023 Nov 18 View PubMed Gopalratnam K, Odeyemi Y, Del Valle KT, Frank RD, Jentzer JC, Gajic O, DuBrock HM. Characteristics and Outcomes of Critically Ill Patients With Pulmonary Hypertension Who Undergo Endotracheal Intubation and Mechanical Ventilation. J Intensive Care Med. 2023 Dec; 38 (12):1174-1182 Epub 2023 July 16 View PubMed Miranda WR, Charles Jain C, Frantz RP, DuBrock HM, Connolly HM, Burchill LJ, Egbe AC. Effects of inhaled nitric oxide on Fontan hemodynamics in adults. J Heart Lung Transplant. 2023 Oct; 42 (10):1349-1352 Epub 2023 Apr 29 View PubMed DuBrock HM. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation. Chest. 2023 Jul; 164 (1):206-214 Epub 2023 Jan 14 View PubMed Baqir M, Singam NS, DuBrock H. Pulmonary hypertension in ANCA-associated vasculitis: a retrospective analysis. Sarcoidosis Vasc Diffuse Lung Dis. 2023 Jun 29; 40 (2):e2023020 Epub 2023 June 29 View PubMed DuBrock HM, Forde K, Krok K, Patel M, Al-Naamani N, Lin G, Oh JK, Fallon MB, Kawut SM, Krowka MJ. Cardiac index and hepatopulmonary syndrome in liver transplantation candidates: The pulmonary vascular complications of liver disease study. Liver Transpl. 2023 May 1; 29 (5):467-475 Epub 2023 Mar 03 View PubMed Cox-Flaherty K, Moutchia J, Krowka MJ, Al-Naamani N, Fallon MB, DuBrock H, Forde KA, Krok K, Doyle MF, Kawut SM, Ventetuolo CE. Six-Minute walk distance predicts outcomes in liver transplant candidates. Liver Transpl. 2023 May 1; 29 (5):521-530 Epub 2023 Jan 25 View PubMed Fayyaz AU, Sabbah MS, Dasari S, Griffiths LG, DuBrock HM, Wang Y, Charlesworth MC, Borlaug BA, Jenkins SM, Edwards WD, Redfield MM. Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension. Cardiovasc Res. 2023 Mar 17; 119 (1):268-282 View PubMed Nathan SD, Deng C, King CS, DuBrock HM, Elwing J, Rajagopal S, Rischard F, Sahay S, Broderick M, Shen E, Smith P, Tapson VF, Waxman AB. Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes. Chest. 2023 Feb; 163 (2):398-406 Epub 2022 Sept 15 View PubMed Cajigas HR, Burger CD, Cartin-Ceba R, DuBrock H, Swanson K, Vargas HE, Keaveny AP, Watt KD, Krowka M. Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry. Mayo Clin Proc. 2022 Dec; 97 (12):2236-2247 Epub 2022 Nov 03 View PubMed Del Valle KT, Krowka MJ, Heimbach JK, Taner T, DuBrock HM. Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes. Transplant Direct. 2022 Dec; 8 (12):e1410 Epub 2022 Nov 11 View PubMed Yarlas A, Mathai SC, Nathan SD, DuBrock HM, Morland K, Anderson N, Kosinski M, Lin X, Classi P. Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative Review. Chest. 2022 Nov; 162 (5):1163-1175 Epub 2022 Aug 23 View PubMed DuBrock HM, Reddy YN, Durst LA, Schroeder DR, Park G, Cajigas HR, Kane GC, Kushwaha SS, McCully RB, Murphy JG, Anand V, Krowka MJ, Frantz RP. The feasibility and value of assessing patient-reported outcomes in pulmonary arterial hypertension. Pulm Circ. 2022 Oct; 12 (4):e12143 Epub 2022 Oct 01 View PubMed Agboola KM, Kowlgi GN, Csecs I, DuBrock HM, Cajigas HR, Allison TG. Bezold-Jarisch reflex mediated syncope in pulmonary arterial hypertension: An illustrative case series. Pulm Circ. 2022 Oct; 12 (4):e12147 Epub 2022 Oct 01 View PubMed DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ, PHAR Investigators. Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2022 Oct; 12 (4):e12172 Epub 2022 Dec 15 View PubMed Omote K, Sorimachi H, Obokata M, Reddy YNV, Verbrugge FH, Omar M, DuBrock HM, Redfield MM, Borlaug BA. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications. Eur Heart J. 2022 Sep 21; 43 (36):3417-3431 View PubMed Izzy M, DuBrock HM. CAQ Corner: Cardiovascular and pulmonary evaluation of liver transplantation candidates: What you need to know for the board exam. Liver Transpl. 2022 Sep; 28 (9):1529-1538 Epub 2022 June 20 View PubMed Hemnes AR, Leopold JA, Radeva MK, Beck GJ, Abidov A, Aldred MA, Barnard J, Rosenzweig EB, Borlaug BA, Chung WK, Comhair SAA, Desai AA, Dubrock HM, Erzurum SC, Finet JE, Frantz RP, Garcia JGN, Geraci MW, Gray MP, Grunig G, Hassoun PM, Highland KB, Hill NS, Hu B, Kwon DH, Jacob MS, Jellis CL, Larive AB, Lempel JK, Maron BA, Mathai SC, McCarthy K, Mehra R, Nawabit R, Newman JH, Olman MA, Park MM, Ramos JA, Renapurkar RD, Rischard FP, Sherer SG, Tang WHW, Thomas JD, Vanderpool RR, Waxman AB, Wilcox JD, Yuan JX, Horn EM, PVDOMICS Study Group. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease. J Am Coll Cardiol. 2022 Aug 16; 80 (7):697-718 View PubMed DuBrock HM, Del Valle KT, Krowka MJ. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception. Liver Transpl. 2022 Jul; 28 (7):1224-1230 Epub 2022 Apr 21 View PubMed Wallace LA, Hocker SE, Dubrock H, Bauer P. Diabetic ketoacidosis, cerebral venous sinus thrombosis and fulminant cerebral oedema in COVID-19 infection complicated by Klebsiella pneumoniae infection. BMJ Case Rep. 2022 Apr 4; 15 (4) Epub 2022 Apr 04 View PubMed Morgan A, Rhee L, DuBrock H. Palliative Care and Pulmonary Arterial Hypertension Advances in Pulmonary Hypertension. 2022; 21(1):1. Aragon Pinto C, Iyer V, Almodallal YA, Albitar H, Dubrock H, Cajigas H, Heimbach JK, Rosen CB, Watt K, Taner T, Nyberg S, Vargas H, Cartin-Ceba R, Keaveny AP, Krowka M, Gallo de Moraes A. ICU and Hospital Outcomes in Patients with Hepatopulmonary Syndrome Undergoing Liver Transplantation. Lung. 2022 Feb; 200 (1):5-10 Epub 2022 Jan 10 View PubMed Burger CD, DuBrock HM, Cartin-Ceba R, Moss JE, Shapiro BP, Frantz RP. Topic-Based, Recent Literature Review on Pulmonary Hypertension. Mayo Clin Proc. 2021 Dec; 96 (12):3109-3121 Epub 2021 Aug 31 View PubMed Aragon Pinto C, Iyer VN, Albitar HAH, Anderson A, Cajigas H, Simonetto DA, Krowka MJ, DuBrock HM, Gallo de Moraes A. Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: A systematic review. Respir Med Res. 2021 Nov; 80:100852 Epub 2021 July 30 View PubMed Nathan SD, Waxman A, Rajagopal S, Case A, Johri S, DuBrock H, De La Zerda DJ, Sahay S, King C, Melendres-Groves L, Smith P, Shen E, Edwards LD, Nelsen A, Tapson VF. Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study. Lancet Respir Med. 2021 Nov; 9 (11):1266-1274 Epub 2021 June 29 View PubMed Del Valle K, DuBrock HM. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Pulmonary Vascular Complications of Liver Disease. Compr Physiol. 2021 Oct 12; 11 (4):3281-3302 View PubMed Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, Heimbach J, Taner T, Nyberg S, Rosen C, Cajigas H, DuBrock H, Krowka MJ. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension. Transplantation. 2021 Oct 1; 105 (10):2283-2290 View PubMed Highland KB, Crawford R, Classi P, Morrison R, Doward L, Nelsen AC, Castillo H, Mathai SC, DuBrock HM. Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure. Health Qual Life Outcomes. 2021 Aug 24; 19 (1):202 View PubMed DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ. Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2021 Jul-Sep; 11 (3):20458940211020913 Epub 2021 May 17 View PubMed Peters BJ, Rabinstein AA, DuBrock HM. Use of Remdesivir in Myasthenia gravis and COVID-19. Pharmacotherapy. 2021 Jun; 41 (6):546-550 Epub 2021 Apr 27 View PubMed Vallabhajosyula S, Shankar A, Vojjini R, Cheungpasitporn W, Sundaragiri PR, DuBrock HM, Sekiguchi H, Frantz RP, Cajigas HR, Kane GC, Oh JK. Impact of Right Ventricular Dysfunction on Short-term and Long-term Mortality in Sepsis: A Meta-analysis of 1,373 Patients. Chest. 2021 Jun; 159 (6):2254-2263 Epub 2021 Feb 27 View PubMed DuBrock HM, Nathan SD, Reeve BB, Kolaitis NA, Mathai SC, Classi PM, Nelsen AC, Olayinka-Amao B, Norcross LN, Martin SA. Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life. Pulm Circ. 2021 Apr-Jun; 11 (2):20458940211005641 Epub 2021 Apr 01 View PubMed DuBrock HM, Cartin-Ceba R, Channick RN, Kawut SM, Krowka MJ. Sex Differences in Portopulmonary Hypertension. Chest. 2021 Jan; 159 (1):328-336 Epub 2020 Aug 13 View PubMed DuBrock HM, Runo JR, Sadd CJ, Burger CD, Cartin-Ceba R, Rosen CB, Taner T, Nyberg SL, Heimbach JK, Findlay JY, Krowka MJ. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure >/=35 mm Hg. Transplant Direct. 2020 Dec; 6 (12):e630 Epub 2020 Nov 10 View PubMed Anand V, Vallabhajosyula S, Cheungpasitporn W, Frantz RP, Cajigas HR, Strand JJ, DuBrock HM. Inpatient Palliative Care Use in Patients With Pulmonary Arterial Hypertension: Temporal Trends, Predictors, and Outcomes. Chest. 2020 Dec; 158 (6):2568-2578 Epub 2020 Aug 12 View PubMed Miranda WR, Jain CC, Connolly HM, DuBrock HM, Cetta F, Egbe AC, Hagler DJ. Prevalence of pulmonary hypertension in adults after atrial switch and role of ventricular filling pressures. Heart. 2020 Oct 7 Epub 2020 Oct 07 View PubMed DuBrock HM, Krowka MJ. The Myths and Realities of Portopulmonary Hypertension. Hepatology. 2020 Oct; 72 (4):1455-1460 View PubMed DuBrock HM, Krowka MJ. Bubble Trouble in COVID-19. Am J Respir Crit Care Med 2020 Oct 1; 202 (7):926-928 View PubMed Jain CC, Warnes CA, Egbe AC, Cetta F, DuBrock HM, Connolly HM, Miranda WR. Hemodynamics in Adults With the Shone Complex. Am J Cardiol. 2020 Sep 1; 130:137-142 Epub 2020 June 16 View PubMed DuBrock HM, Krowka MJ, Krok K, Forde K, Mottram C, Scanlon P, Al-Naamani N, Patel M, McCormick A, Fallon MB, Kawut SM. Prevalence and Impact of Restrictive Lung Disease in Liver Transplant Candidates. Liver Transpl. 2020 Aug; 26 (8):989-999 Epub 2020 July 09 View PubMed Albitar HAH, Almodallal Y, Gallo De Moraes A, O'Brien E, Choby GW, Pruthi RK, Stokken JK, Kamath PS, Cajigas HR, DuBrock HM, Krowka MJ, Iyer VN. Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia-Related Bleeding and High-Output Cardiac Failure: Significant Inter-Individual Variability in the Need for Maintenance Therapy. Mayo Clin Proc. 2020 Aug; 95 (8):1604-1612 View PubMed Deljou A, Sabov M, Kane GC, Frantz RP, DuBrock HM, Martin DP, Schroeder DR, Johnson MQ, Weingarten TN, Sprung J. Outcomes After Noncardiac Surgery for Patients with Pulmonary Hypertension: A Historical Cohort Study. J Cardiothorac Vasc Anesth. 2020 Jun; 34 (6):1506-1513 Epub 2019 Nov 09 View PubMed Anand V, Frantz RP, DuBrock H, Kane GC, Krowka M, Yanagisawa R, Sandhu GS. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience. Mayo Clin Proc Innov Qual Outcomes. 2019 Sep; 3 (3):311-318 Epub 2019 Aug 23 View PubMed DuBrock HM, Salgia RJ, Sussman NL, Bartolome SD, Kadry Z, Mulligan DC, Jenkins S, Lackore K, Channick RN, Kawut SM, Krowka MJ. Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes. Transplant Direct. 2019 Jun; 5 (6):e456 Epub 2019 May 22 View PubMed Fayyaz AU, Edwards WD, Maleszewski JJ, Konik EA, DuBrock HM, Borlaug BA, Frantz RP, Jenkins SM, Redfield MM. Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction. Circulation. 2018 Apr 24; 137 (17):1796-1810 Epub 2017 Dec 15 View PubMed DuBrock HM, Krowka MJ, Forde KA, Krok K, Patel M, Sharkoski T, Sprys M, Lin G, Oh JK, Mottram CD, Scanlon PD, Fallon MB, Kawut SM. Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant. Chest. 2018 Feb; 153 (2):414-426 Epub 2017 Oct 05 View PubMed Iyer VN, Apala DR, Pannu BS, Kotecha A, Brinjikji W, Leise MD, Kamath PS, Misra S, Begna KH, Cartin-Ceba R, DuBrock HM, Krowka MJ, O'Brien EK, Pruthi RK, Schroeder DR, Swanson KL. Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding. Mayo Clin Proc. 2018 Feb; 93 (2):155-166 Epub 2018 Jan 24 View PubMed DuBrock HM, AbouEzzeddine OF, Redfield MM. High-sensitivity C-reactive protein in heart failure with preserved ejection fraction. PLoS One. 2018; 13 (8):e0201836 Epub 2018 Aug 16 View PubMed DuBrock HM, J Krowka M. Do Late Bubbles Correspond to Early Hepatopulmonary Syndrome? Ann Hepatol 2017 Jul-Aug; 16 (4):476-477 View PubMed DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation. 2017 Jul; 101 (7):1609-1615 View PubMed DuBrock HM, Rodriquez-Lopez JM, LeVarge BL, Curry MP, VanderLaan PA, Zsengeller ZK, Pernicone E, Preston IR, Yu PB, Nikolic I, Xu D, Thadhani RI, Channick RN, Kaumanchi SA. Macrophage migration inhilbitory factor as a novel biomarker fo portopulmonary hypertension Pulmonary Circulation.2016;6:(4)498-507. Michaud GC, Channick CL, Law AC, McCannon JB, Antkowiak M, Garrison G, Sayah D, Huynh RH, Brady AK, Adamson R, DuBrock H, Akuthota P, Marion C, Dela curz C, Town JA, Coruh B, Thomson CC. ATS Core Curriculum 2016. Part IV: Adult Pulmonary Medicine COre Curriculum Annals ATS.2016;13:(7)1160-1169. DuBrock HM, Kradin R, Rodriquez-Lopez J, Channick RN. Pulmonary Capillary Hemangiomatosis: The role of invasive cardiopulmonary exercise testing Pulmoanry Circulation.2015;5:(3):580-586. Michaud GC, Channick CL, Marion CR, Tighe RM, Town JA, Luks AM, Richards JB, Kher S, Mota P, Hong G, West NE, Rackley C, Neilans L, Rodriguez-Lopez J, DuBrock H, Kennedy CC, Kelm DJ, Thomson CC. ATS Core Curriculum 2015. Part I: Adult Pulmonary Medicine. Ann Am Thorac Soc. 2015 Sep; 12 (9):1387-97 View PubMed DuBrock HM, Channick RN, Krowka MJ. What's new in the treatment of portopulmonary hypertension? Expert Review Of Gastroenterology & Hepatology. 2015 Jul; 9: (7)983-92. View PubMed DuBrock HM, Bankier AA, Silva M, Litmanovich DE, Curry MP, Washko GR. Pulmonary Vessel Cross-sectional Area before and after Liver Transplantation: Quantification with Computed Tomography. Acad Radiol. 2015 Jun; 22: (6)752-9. View PubMed DuBrock HM, Clardy PF. Palpitations, hypotension, hypokalemia, and hyperlactatemia. Putting the pieces together. Ann Am Thorac Soc. 2014 Oct; 11: (8)1319-22. View PubMed DuBrock HM, Channick RN. Macitentan for the treatment of pulmonary arterial hypertension. Expert Rev Respir Med. 2014 Aug; 8: (4)393-9. View PubMed Boiselle PM, Litmanovich D, Michaud G, Roberts DH, Loring S, Womble H, Millett M, O'Donnell C. Dynamic Expiratory collapse in morbidly obese COPD patients. Chronic Obstructive Pulmoanry Disease.2013;10:(5)604. Womble H, Schwartzstein R, Johnston R. Effect of Therapeutic hyperoxia on maximal oxygen consumption and perioperative risk stratification in Chronic Obstructive Pulmonary Diesease. Lung.2012;190:(3)263-269. Boiselle PM, Michaud G, Roberts DH, Loring S, Womble H, Millet M, O'Donnell C. Dynamic expiratory tracheal collapse in COPD: Correlation wit hclinical and physiologic parameters. CHEST.2012;142:(6)1539-1544. PST-20268936 الصفحة الرئيسية المنشورات